Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: James Strauss who wrote (224)	7/13/1998 12:39:00 PM
From: Lucin	Read Replies (1) \| Respond to of 534

World Bank, IMF, UNESCO, WHO will be adopting the BIOJECT needle system. I have had a chance to work for an NGO that was affiliated with the World Bank in Kenya, Ethiopia, and Madras. The number of vaccinations given to the local populations in Madras alone was several hundred thousand a month, doctors and nurses were preparing to use the needless injection method. Prior to this syringes were used, these syringes were bought at wholesale but they still comprised a tremendous amount of the budget. A unilateral adoption of this by all organizations including the Red Cross is the next necessary step. While the World Bank and those mentioned before will provide a boost to the stock, it is the Red Cross which has the greatest reach abroad. My only concern now is the complacency of management now to get the news out. This might be a move on their part to slowly accumulate for their own portfolio. If someone could enlighten me, please do so.